• SPX
  • $5,782.76
  • 1.23 %
  • $70.07
  • DJI
  • $42,221.88
  • 1.02 %
  • $427.28
  • N225
  • $39,006.96
  • 1.38 %
  • $532.28
  • FTSE
  • $8,172.39
  • -0.14 %
  • -$11.85
  • IXIC
  • $18,439.17
  • 1.43 %
  • $259.19
Halozyme Therapeutics, Inc. (HALO) Insider Traders

Halozyme Therapeutics, Inc. (HALO) Insider Traders

NASDAQ Currency in USD Disclaimer

Stock Price

$58.74

$0.27

(0.46%)

Day's range
$57.09
Day's range
$58.74
  • NUMBER OF INSIDER BUYING

    (Last 12 Months)

    0
  • NUMBER OF INSIDER SELLING

    (Last 12 Months)

    4
  • AMOUNT OF INSIDERS BUYING

    (Last 12 Months)

    $0
  • AMOUNT OF INSIDERS SELLING

    (Last 12 Months)

    $19.59 M

Halozyme Therapeutics, Inc. Insider Transactions

Halozyme Therapeutics, Inc. Insider Trades History

Insider Name Buy/Sell Shares Bought/Sold
@ Price
Total Transaction Shares Held
After Transaction
Transaction Date Filing Date Details
LaBarre Michael J.

SVP, CHIEF TECHNICAL OFFICER

Sell 10,000 @ $53.26 $532,590 173,756 10/16/2024 10/16/2024
LaBarre Michael J.

SVP, CHIEF TECHNICAL OFFICER

Sell 9,923 @ $53.74 $533,292 173,833 10/15/2024 10/16/2024
LaBarre Michael J.

SVP, CHIEF TECHNICAL OFFICER

Sell 77 @ $54.25 $4,177 173,756 10/15/2024 10/16/2024
Sell 5,981 @ $51.85 $310,097 680,763 10/09/2024 10/09/2024
Sell 1,615 @ $53.31 $86,096 679,148 10/09/2024 10/09/2024
Sell 2,404 @ $53.91 $129,590 676,744 10/09/2024 10/09/2024
Sell 9,100 @ $53.94 $490,845 677,644 10/08/2024 10/09/2024
Sell 900 @ $54.57 $49,116 676,744 10/08/2024 10/09/2024
Sell 10,000 @ $56.10 $560,970 676,744 09/26/2024 09/26/2024
Sell 10,000 @ $56.34 $563,370 676,744 09/25/2024 09/26/2024
Sell 10,000 @ $58.21 $582,100 676,744 09/24/2024 09/26/2024
LaBarre Michael J.

SVP, CHIEF TECHNICAL OFFICER

Sell 7,963 @ $61.89 $492,838 175,793 09/18/2024 09/18/2024
LaBarre Michael J.

SVP, CHIEF TECHNICAL OFFICER

Sell 2,037 @ $62.58 $127,477 173,756 09/18/2024 09/18/2024
LaBarre Michael J.

SVP, CHIEF TECHNICAL OFFICER

Sell 10,000 @ $62.88 $628,780 173,756 09/17/2024 09/18/2024
Sell 10,000 @ $59.20 $592,030 676,744 09/12/2024 09/12/2024
Sell 10,000 @ $59.09 $590,870 676,744 09/11/2024 09/12/2024
Sell 10,000 @ $59.09 $590,890 676,744 09/10/2024 09/12/2024
LaBarre Michael J.

SVP, CHIEF TECHNICAL OFFICER

Sell 9,900 @ $61.74 $611,236 168,276 08/21/2024 08/21/2024
LaBarre Michael J.

SVP, CHIEF TECHNICAL OFFICER

Sell 100 @ $62.34 $6,234 168,176 08/21/2024 08/21/2024
LaBarre Michael J.

SVP, CHIEF TECHNICAL OFFICER

Sell 10,000 @ $61.06 $610,550 168,176 08/20/2024 08/21/2024

Halozyme Therapeutics, Inc. Congressional Trades History

Member of congress Current Price Type Trade Data Date Filed Date Traded
$58.72 Sale (Partial) $1,001 - $15,000 10/03/2024 09/09/2024

Halozyme Therapeutics, Inc. Frequently Asked Questions

  • Who is on Halozyme Therapeutics, Inc.'s Insider Roster?

    The list of insiders at Halozyme Therapeutics, Inc. includes LaBarre Michael J., Posard Matthew L., LaBrosse Nicole, Torley Helen.

  • How much insider selling is happening at Halozyme Therapeutics, Inc.?

    Insiders have sold a total of 374,881 Halozyme Therapeutics, Inc. shares in the last 12 months for a total of 19.59 M sold.

  • Which Halozyme Therapeutics, Inc. insiders have been selling company stock?

    The following insiders have sold Halozyme Therapeutics, Inc. shares in the last 12 months: LaBarre Michael J. ($8.81 M), Posard Matthew L. ($2.70 M), LaBrosse Nicole ($1.83 M), Torley Helen ($6.26 M),

×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.